Cornerstone Planning Group’s Neurocrine Biosciences NBIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $385 | Hold |
3
| – | – | ﹤0.01% | 1373 |
|
|
2025
Q1 | $310 | Sell |
3
-13
| -81% | -$1.34K | ﹤0.01% | 1403 |
|
|
2024
Q4 | $2.37K | Buy |
+16
| New | +$2.37K | ﹤0.01% | 749 |
|
|
2023
Q3 | – | Sell |
-13
| Closed | -$1.23K | – | 1277 |
|
|
2023
Q2 | $1.23K | Buy |
+13
| New | +$1.23K | ﹤0.01% | 1299 |
|
|
2022
Q4 | $1.43K | Buy |
+13
| New | +$1.43K | ﹤0.01% | 1280 |
|